Press Releases

Press Release: Indica Labs completes nationwide deployment of HALO AP™ at NeoGenomics Laboratories, Inc.

Albuquerque, NM (April 3, 2020) – Indica Labs, the leading provider of computational pathology software, is pleased to announce the formal release of its HALO AP™ Anatomic Pathology platform at NeoGenomics Laboratories, Inc.

HALO AP™ was developed by Indica Labs to address the needs of Anatomic Pathology labs. Offering a full range of tissue-based assays and workflows, the platform can be fully integrated within existing LIS solutions or can operate as a standalone case management system. HALO AP adds support for clinical trials, tumor boards, secondary consults, AI-assisted workflows, and quantitative analysis of custom laboratory developed tests (LDTs), from basic immunohistochemistry (IHC) through to novel, multiplexed immune-oncology assays.

Press Release: Indica Labs completes nationwide deployment of HALO AP™ at NeoGenomics Laboratories, Inc. Read More »

Press Release: NeoGenomics Integrates HALO® From Indica Labs

Ft. Myers, Florida – March 31, 2020 – NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused testing services, today announced that it has integrated Indica Labs enterprise-level HALO AP™ image analysis platform for Image Analysis, Immunohistochemistry (IHC) and Multiplexing across its Clinical Services and Pharma Services businesses. The platform’s robust workflow modules streamlines analysis algorithms and provides rapid, quantitative results for a multitude of tissue types.

Press Release: NeoGenomics Integrates HALO® From Indica Labs Read More »

Press Release: IONpath and Indica Labs establish a co-marketing agreement to promote spatially resolved analysis of tissues imaged with the Multiplexed Ion Beam Imaging (MIBI) System

USA 04/26/2019 – Indica Labs and IONpath announced today that a co-marketing agreement has been established to jointly promote their respective technologies for tissue-based, multiplexed

Press Release: IONpath and Indica Labs establish a co-marketing agreement to promote spatially resolved analysis of tissues imaged with the Multiplexed Ion Beam Imaging (MIBI) System Read More »

Press Release: Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ: FLDM) and Indica Labs, Inc., today announced a co-marketing relationship for scalable and

Press Release: Fluidigm Announces Co-Marketing Agreement with Indica Labs to Offer Platform for Imaging Mass Cytometry Data Analysis to Aid Novel Digital Pathology Investigations Read More »

Scroll to Top